Role of antibodies and cellular immune responses in hepatitis C virus-induced infection;Rôle des anticorps neutralisants et de l'immunité cellulaire dans l'infection à VHC

Transfusion Clinique et Biologique

Volumn 8, Issue 6, 2001, Pages 471-474

  Inchauspe G ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Acute infection; Antibodies; Cellular mediated immune responses; Chronic infection; Dendritic cells; Hepatitis C virus

Indexed keywords

GLYCOPROTEIN E; NEUTRALIZING ANTIBODY;

ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; DENDRITIC CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; LIVER CANCER; LIVER CIRRHOSIS; PERSISTENT VIRUS INFECTION; T LYMPHOCYTE;

EID: 18244367938     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(01)00201-4     Document Type: Article

References (23)

1. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
2. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection
3. Mixed cryoglobulinaemia and hepatitis C virus
4. Cryoglobulinaemia and hepatitis C virus
5. Hepatitis C virus infection in patients with lymphoproliferative disorders
6. Herpes Simplex virus turns off the TAP to evade host immunity
7. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: A new marker of HCV infection closely associated with viremia
8. The hepatitis C virus
9. Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus
10. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library
11. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NSI proteins and the pestivirus envelope glycoproteins
12. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus
13. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients
14. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorometric assessment of envelope glycoprotein 2 binding to target cells
15. Conformational epitopes detected by cross-reactive antibodies to envelope 2 glycoprotein of the hepatitis C virus
16. T-lymphocyte response to hepatitis C virus in different clinical courses of infection
17. T-cell response to structural and non-structural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections
18. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T-cells: Implications for vaccine development
19. Intra-hepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis
20. Induction of cytotoxic T-cells to a cross-reactive epitope in the hepatitis C virus non-structural RNA polymerase-like protein
21. Patients with chronic hepatitis C have circulating cytotoxic T-cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2. 1 molecules
22. Quantitative analysis of hepatitis C virus specific CD8(+) T-cells in peripheral blood and liver using peptide-MHC tetramers
23. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus infected individuals